Literature DB >> 9591724

Synaptophysin staining in normal brain: importance for diagnosis of ganglioglioma.

B Quinn1.   

Abstract

Neuronal and mixed glioneuronal tumors traditionally have comprised a very small percentage of intrinsic central nervous system neoplasms, although they are somewhat more common among juvenile brain tumors and in the temporal lobe. Neuronal differentiation increasingly is recognized in pleomorphic xanthoastrocytoma, intraventricular neurocytoma, and subependymal giant cell astrocytoma. However, the diagnostic distinctions between subtle ganglioglioma (with rare neurons) and infiltrating glioma with entrapped neurons and between infiltrating oligodendroglioma and parenchymal neurocytoma are problematic but may be clinically important. Recently, it was proposed that perisomatic synaptophysin immunostaining in the human central nervous system reliably and selectively discriminates neoplastic from nonneoplastic neurons. Using this criterion, the number of brain stem and spinal cord gangliogliomas could be increased substantially. We canvassed synaptophysin immunostaining patterns in the normal brain stem, cerebellum, and forebrain, and found that synaptophysin-positive neurons are distributed broadly in the normal human brain. In disturbed neocortical tissue, such as near vascular malformations, synaptophysin-positive neurons and irregular white-matter synaptophysin immunostaining are visualized. Although synaptophysin-positive neurons are found in gangliogliomas and archipelagos of synaptophysin reactivity are found in neurocytomas, these patterns clearly are not pathognomonic for glioneuronal tumors and must be interpreted with caution whenever other histologic or ultrastructural evidence of neuronal differentiation is lacking.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9591724     DOI: 10.1097/00000478-199805000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

Review 1.  Neurocytoma: a comprehensive review.

Authors:  Mehar Chand Sharma; Prabal Deb; Suash Sharma; Chitra Sarkar
Journal:  Neurosurg Rev       Date:  2006-08-29       Impact factor: 3.042

2.  Surgical pathology of intramedullary spinal cord neoplasms.

Authors:  D C Miller
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

3.  So-called malignant and extra-ventricular neurocytomas: reality or wrong diagnosis? A critical review about two overdiagnosed cases.

Authors:  A V Vallat-Decouvelaere; P Gauchez; P Varlet; M B Delisle; M Popovic; H Boissonnet; M Gigaud; J Mikol; J Hassoun
Journal:  J Neurooncol       Date:  2000-06       Impact factor: 4.130

4.  Expression of synaptic vesicle protein 2A in epilepsy-associated brain tumors and in the peritumoral cortex.

Authors:  Marjolein de Groot; Sjoukje T Toering; Karin Boer; Wim G M Spliet; Jan J Heimans; Eleonora Aronica; Jaap C Reijneveld
Journal:  Neuro Oncol       Date:  2010-01-06       Impact factor: 12.300

5.  Massive dissemination from spinal cord gangliogliomas negative for BRAF V600E: report of two rare adult cases.

Authors:  Seth C Lummus; Dara L Aisner; Sharon B Sams; Nicholas K Foreman; Kevin O Lillehei; B K Kleinschmidt-DeMasters
Journal:  Am J Clin Pathol       Date:  2014-08       Impact factor: 2.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.